Results

Concentrix Corporation

12/06/2021 | Press release | Distributed by Public on 12/06/2021 05:08

Amendments to Articles of Incorporation/Bylaws/Change in Fiscal Year - Form 8-K

cnxc-20211204

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): December 4, 2021
CONCENTRIX CORPORATION
(Exact name of registrant as specified in its charter)

Delaware 001-39494 27-1605762
(State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number)

44111 Nobel Drive, Fremont, California
94538
(Address of principal executive offices) (Zip Code)

(800) 747-0583
(Registrant's telephone number, including area code)

N/A
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))



Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.0001 per share CNXC The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On December 4, 2021, the Board of Directors (the "Board") of Concentrix Corporation (the "Company") adopted an amendment (the "Amendment") to the Amended and Restated Bylaws of the Company (the "Bylaws"), effective immediately. The Amendment changed the required vote of stockholders necessary to remove a director, with or without cause, set forth in Section 3.4 of the Bylaws from two-thirds of the voting power of the capital stock issued and outstanding then entitled to vote at an election of directors to a majority of the voting power of the capital stock issued and outstanding then entitled to vote at an election of directors.
The foregoing summary of the Amendment is qualified in its entirety by reference to the full text of the Amendment, which is filed as Exhibit 3.2 to this Current Report on Form 8-K and is incorporated herein by reference.


Item 9.01. Financial Statements and Exhibits.
Exhibit No.
Description
3.2
Amendment No. 1 to the Amended and Restated Bylaws of Concentrix Corporation.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: December 6, 2021
CONCENTRIX CORPORATION
By: /s/ Jane C. Fogarty
Jane C. Fogarty
Executive Vice President, Legal